Viewing Study NCT01308658

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:19 AM

Ignite Modification Date: 2025-12-30 @ 11:42 PM

Study NCT ID: NCT01308658

Status: COMPLETED

Last Update Posted: 2014-02-06

First Post: 2011-02-03

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions

Sponsor: Tibotec Pharmaceuticals, Ireland

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module